{
"NDC": {
"NDCCode": "61786-195-36",
"PackageDescription": "24 TABLET in 1 BOTTLE (61786-195-36)",
"NDC11Code": "61786-0195-36",
"ProductNDC": "61786-195",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Leader Migraine Formula",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Acetaminophen, Aspirin, Caffeine",
"DosageFormName": "TABLET",
"RouteName": "ORAL",
"StartMarketingDate": "20150303",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA075794",
"LabelerName": "REMEDYREPACK INC.",
"SubstanceName": "ACETAMINOPHEN; ASPIRIN; CAFFEINE",
"StrengthNumber": "250; 250; 65",
"StrengthUnit": "mg/1; mg/1; mg/1",
"Pharm_Classes": "Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient]",
"DEASchedule": null,
"Status": "Deprecated",
"LastUpdate": "2017-03-20",
"PackageNdcExcludeFlag": null,
"ProductNdcExcludeFlag": null,
"ListingRecordCertifiedThrough": null,
"StartMarketingDatePackage": null,
"EndMarketingDatePackage": null,
"SamplePackage": null
}
}